Scopolamine Patch Pharmacokinetics in Healthy Adults
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The study to be performed will utilize already FDA-approved marketed products in healthy
adults for the purpose to generate data for establishing rate of drug delivery of Transderm
Scop® TDDS (transdermal drug delivery system) in healthy adults and to ensure safety of
individuals utilizing these types of products.
Phase:
Phase 4
Details
Lead Sponsor:
University of Iowa
Collaborators:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute